Filing Flows

Filing Flows › Insight Molecular Diagnostics (IMDX) › Who owns the stock

Who owns Insight Molecular Diagnostics (IMDX) stock

41 funds reported Insight Molecular Diagnostics (IMDX) shares in their latest 13F filings, worth $93.3M in all. The largest holder is Broadwood Capital ($74.8M). Last quarter 20 funds added to their stakes and 19 cut them.

Largest holders of IMDX (13F)Largest holders of IMDX (13F)Broadwood Capital$74.8MVanguard Capital Management LLC$4.3MVanguard Group$4.0MFamily Office Research LLC$2.3MGeode Capital Management, LLC$1.5MJane Street Group, LLC$930KBlackRock$888KFNY Investment Advisers, LLC$869KVanguard Fiduciary Trust$735KState Street$544K

Largest holders (13F)

FundSharesValueChangeQuarter
Broadwood Capital12,684,884$74.8Mincrease2026-06-30
Vanguard Capital Management LLC735,847$4.3Mincrease2026-06-30
Vanguard Group526,675$4.0Mincrease2025-12-31
Family Office Research LLC650,234$2.3Mincrease2026-09-30
Geode Capital Management, LLC256,903$1.5Mdecrease2026-06-30
Jane Street Group, LLC157,682$930Knew2026-06-30
BlackRock150,521$888Kincrease2026-06-30
FNY Investment Advisers, LLC242,264$869Kincrease2026-09-30
Vanguard Fiduciary Trust124,576$735Kdecrease2026-06-30
State Street92,124$544Kincrease2026-06-30
Millennium Management LLC82,499$487Knew2026-06-30
UBS Group AG53,276$314Kincrease2026-06-30
Northern Trust49,090$290Kunchanged2026-06-30
Osaic Holdings39,136$231Kincrease2026-06-30
Morgan Stanley35,515$210Kdecrease2026-06-30

Insight Molecular Diagnostics' latest quarter

Insight Molecular Diagnostics, Q2 2026: revenue $239K (-54% year over year), net loss $11.3M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most IMDX stock?

By the latest 13F filings: Broadwood Capital ($74.8M); Vanguard Capital Management LLC ($4.3M); Vanguard Group ($4.0M); Family Office Research LLC ($2.3M); Geode Capital Management, LLC ($1.5M).

What is the short interest in IMDX?

949,512 shares were sold short at the 2026-10-15 settlement, -2.42% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.